Template:Brain abscess antibiotics: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | *[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | ||
====Sinogenic or odontogenic source==== | ====Sinogenic or odontogenic source==== | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | |||
====Penetrating trauma or neurosurgical procedures==== | ====Penetrating trauma or neurosurgical procedures==== | ||
*[[Vancomycin]] 15mg/kg IV q12hr + [[ceftazidime]] 2gm IV q8hr | *[[Vancomycin]] 15mg/kg IV q12hr + [[ceftazidime]] 2gm IV q8hr | ||
Latest revision as of 20:37, 6 July 2015
Otogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Sinogenic or odontogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Penetrating trauma or neurosurgical procedures
- Vancomycin 15mg/kg IV q12hr + ceftazidime 2gm IV q8hr
Hematogenous source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
No obvious source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr